Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection
- PMID: 17868184
- DOI: 10.1002/jgm.1104
Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection
Abstract
Background: Adiponectin (Adipo), an adipocyte hormone involved in the regulation of glucose and lipid metabolism, has already been identified as a potential therapeutic target for the treatment of diabetes. However, successful delivery of Adipo to the receptors is difficult due to their peptide characteristics. Receptors for Adipo are abundantly expressed in the liver and skeletal muscle.
Methods: Uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG) in hepatoblastoma HepG2 cells expressing Adipo was examined. Adipo-expressing plasmid DNA (10-50 microg) in saline solution (0.1 ml/g body weight) was rapidly injected into the tail vein of 4-week-old diabetic mice after 4-6 weeks of treatment with streptozotocin (STZ). Uptake of glucose in diabetic mice also was measured using a planar positron imaging system featuring 18-fluorodeoxyglucose.
Results: HepG2 cells expressing Adipo exhibited significantly increased 2-NBDG uptake compared with cells transfected with control plasmid even in the absence of insulin. STZ-induced diabetic mice showed decreased serum Adipo levels compared with non-diabetic mice. A single hydrodynamic injection of 10-50 microg Adipo-expressing plasmid DNA into diabetic mice led to approximately 10-15-fold elevation in serum Adipo levels, and resulted in decreased serum levels of glucose and triglyceride. As well as exhibiting higher levels of Adipo expression, diabetic mice also had higher hepatic glucose uptake than similar mice injected with control plasmid.
Conclusions: We report that STZ-induced diabetic mice exhibited decreased Adipo levels and hyperglycemia which may be alleviated by hydrodynamic injection of the Adipo gene. This type of gene delivery system to the liver offers a different approach in developing novel treatments for type 1 and 2 diabetes.
2007 John Wiley & Sons, Ltd
Similar articles
-
Construction of adiponectin-encoding plasmid DNA and gene therapy of non-obese type 2 diabetes mellitus.J Drug Target. 2010 Jan;18(1):67-77. doi: 10.3109/10611860903225719. J Drug Target. 2010. PMID: 19708766
-
Role of adiponectin in the regulation of carbohydrate and lipid metabolism.J Physiol Pharmacol. 2006 Nov;57 Suppl 6:103-13. J Physiol Pharmacol. 2006. PMID: 17228091 Review.
-
Gene therapy progress and prospects: hydrodynamic gene delivery.Gene Ther. 2007 Jan;14(2):99-107. doi: 10.1038/sj.gt.3302891. Epub 2006 Nov 30. Gene Ther. 2007. PMID: 17167496 Review.
-
Intramuscular injection of naked plasmid DNA encoding human preproinsulin gene in streptozotocin-diabetes mice results in a significant reduction of blood glucose level.Sheng Li Xue Bao. 2003 Dec 25;55(6):641-7. Sheng Li Xue Bao. 2003. PMID: 14695479
-
Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes.J Gene Med. 2003 May;5(5):425-37. doi: 10.1002/jgm.359. J Gene Med. 2003. PMID: 12731091
Cited by
-
Hydrodynamic Delivery: Characteristics, Applications, and Technological Advances.Pharmaceutics. 2023 Mar 31;15(4):1111. doi: 10.3390/pharmaceutics15041111. Pharmaceutics. 2023. PMID: 37111597 Free PMC article. Review.
-
Remodeling adipose tissue inflammasome for type 2 diabetes mellitus treatment: Current perspective and translational strategies.Bioeng Transl Med. 2019 Dec 13;5(2):e10150. doi: 10.1002/btm2.10150. eCollection 2020 May. Bioeng Transl Med. 2019. PMID: 32440558 Free PMC article. Review.
-
Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus.World J Diabetes. 2018 Jun 15;9(6):80-91. doi: 10.4239/wjd.v9.i6.80. World J Diabetes. 2018. PMID: 29988851 Free PMC article.
-
Translational Advances of Hydrofection by Hydrodynamic Injection.Genes (Basel). 2018 Mar 1;9(3):136. doi: 10.3390/genes9030136. Genes (Basel). 2018. PMID: 29494564 Free PMC article. Review.
-
Suppression of GRK2 expression reduces endothelial dysfunction by restoring glucose homeostasis.Sci Rep. 2017 Aug 16;7(1):8436. doi: 10.1038/s41598-017-08998-5. Sci Rep. 2017. PMID: 28814745 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials